Congress quietly extends tick-disease research funding for five more years

What it does

This bill extends federal funding and programs for tick-borne disease research and prevention for five more years (2026–2030), replacing the expiring 2021–2025 authorization. It updates the governance structure of the national strategy by clarifying which officials participate and expands the scope of regional centers to include capacity-building for disease identification, reporting, prevention, and response.

Why we flagged it

The bill is a routine extension of existing federal vector-borne disease programs. It contains no new policy, no private carve-outs, and no controversial provisions—only a five-year renewal of funding authority and minor administrative clarifications to the governance structure.

What the text implies

• The bill updates the reference from the Tick-Borne Disease Working Group (established under the 21st Century Cures Act) to the statutory citation (42 U.S.C. § 284s), which may reflect a structural reorganization of that working group but does not change its function or authority.
• Expansion of regional centers' scope to explicitly include 'capacity to identify, report, prevent, and respond' may enable broader surveillance and response infrastructure, potentially increasing federal coordination with state and local health departments.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill extends public health infrastructure for tick-borne disease prevention and research, which directly benefits citizens by maintaining federal capacity to identify, prevent, and respond to diseases like Lyme disease. No restrictions on citizen rights or remedies are imposed; the bill is a straightforward reauthorization of existing public-health programs.

Who stands to gain

• state and local health departments
• academic medical centers and research institutions receiving grants for vector-borne disease researc

Named in the bill

Public Health Service Act, 21st Century Cures Act, Tick-Borne Disease Working Group, National Institutes of Health (implied), Centers for Disease Control and Prevention (implied), state and local health departments

Where it stands

36 cosponsors: 28 Democrats, 8 Republicans.

• Jul 10, 2025 — Introduced · Congress.gov: “Introduced in House”
• Jul 10, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
• May 13, 2026 — Markup held in committee · Congress.gov: “Subcommittee Consideration and Mark-up Session Held”
• May 21, 2026 — Reported out of committee · Congress.gov: “Ordered to be Reported by the Yeas and Nays: 48 - 0”
• Jul 20, 2026 — Passed the House · Congress.gov: “On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4640)”
• Jul 20, 2026 — Floor vote scheduled · Congress.gov: “Mr. Guthrie moved to suspend the rules and pass the bill”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $90,000 in lobbying spend. A filing names 10 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Chris Smith, the sponsor, reported $236,256 in PAC receipts in the 2026 cycle.

• University of Wisconsin-madison — $60,000 on 1 filing
• Entomological Society of America — $30,000 on 1 filing

Lobbying Disclosure Act filings through Jul 15, 2026. A filing shows who paid to lobby on a bill it names, not what changed.